Hexo: Analysts Anticipate $34.4 Million In Q3 Revenues

Hexo Corp (TSX: HEXO) (NYSE: HEXO) announced that they will be reporting their fiscal third quarter financials before the market opens on June 14th.

Analysts have a consensus C$9.47 12-month price target on the company, via a total of 25 analysts, with three analysts having buy ratings, eight analysts have hold ratings and a single analyst has a strong sell rating. The street high comes from Alliance Global with a C$14 price target, and the lowest target comes from Bryan Garnier with a C$4 price target.

10 analysts have revenue estimates for the third quarter. The mean between all 10 is C$34.42 million; this number has been steady since the start of the year. The street high is C$36.90 million while the lowest sits at C$28.30 million.

Six analysts have estimates for what this quarter’s gross profit margin will be. They expect the profit margin to come in at 36.08%, with this number being flat since the start of the year. Street high goes to Stifel-GMP with a 37% estimate and the lowest sits at 35.1%.

Onto EBITDA estimates, there are currently 10 analysts who have third quarter EBITDA estimates. The mean is currently C$0.068 million, with this number being lower at the start of the year. Street high goes to Oppenheimer with a C$2.6 million EBITDA estimate and the lowest being a (C$2) million estimate.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

First Majestic Q3 Earnings: Another RECORD Quarter!

Barrick Q3 Earnings: Juicing Shareholder Returns Amid Declining Production

Wheaton Q3 Earnings: Cash Operating Margins Skyrocket

Recommended

Canadian Copper Set To Submit Environmental Impact Assessment In H1 2026 For Murray Brook

Goliath Resources Extends High Grade Zone To 580 Metres In Latest Assays

Related News

Organigram: Analysts Upgrade Targets Following BAT Investment

On March 9th, Organigram Holdings (TSX: OGI) (NASDAQ: OGI) announced that they received a C$221...

Sunday, March 14, 2021, 06:32:00 PM

Beyond Meat: Analysts Anticipate $113.33 Million In Q1 Revenues

Beyond Meat (NASDAQ: BYND) will be reporting its first quarter financial results today after market...

Thursday, May 6, 2021, 02:34:00 PM

Zenabis Reports Q4 Revenues Of $15.9 Million, Net Loss Of $30.1 Million

Zenabis Global (TSX: ZENA) last night quietly filed its fourth quarter and full year 2020...

Thursday, April 1, 2021, 07:11:14 AM

Aphria: Canaccord, PI Financial Reiterate Ratings And Price Targets After Q1 Financials

Yesterday, Aphria Inc (TSX: APHA) (NASDAQ: APHA) released its fiscal first quarter results. Net revenue...

Friday, October 16, 2020, 10:09:53 AM

Canaccord: “Strike 2, Ball 1” On Lundin Mining’s Announcement Of Strike Notice

On Thursday morning, Canaccord Genuity’s Dalton Baretto sent out a flash update on Lundin Mining...

Thursday, October 8, 2020, 04:01:00 PM